nPhase Series D

Atlantic Beach, Florida-based nPhase, Inc. has closed a $30 million Series D funding round led by Viking Global Investors, marking the company’s first equity capital raise. nPhase plans to use the new funds to accelerate the rollout of its AI-native clinical data platform, which enables pharmaceutical sponsors to scale their AI capabilities and unlock clinical data. Lead investor Viking Global Investors currently manages more than $54 billion in capital across public and private markets.